India's Largest Database on New Projects
Unichem Labs gets USFDA nod
8 April 2011: Unichem Laboratories has received approval from the US Food and Drug Administration (USFDA) to market Divalproex Sodium Delayed Release tablets, indicated for seizure disorders, in the American market. The company has got the nod for Divalproex Sodium Delayed Release tablets in strengths of 125 mg, 250mg and 500 mg. The company already has nine drugs in the US that have been approved by the USFDA.
Source: Hindu Business Line